MENU
+Compare
AKTX
Stock ticker: NASDAQ
AS OF
Jul 10 closing price
Price
$1.15
Change
+$0.02 (+1.79%)
Capitalization
36.25M

AKTX Akari Therapeutics plc Forecast, Technical & Fundamental Analysis

Akari Therapeutics PLC is an oncology company developing next-generation antibody-drug conjugates (ADCs) designed around novel, proprietary cancer-killing toxins (payloads)... Show more

AKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for AKTX with price predictions
Jul 10, 2025

AKTX's Stochastic Oscillator is staying in oversold zone for 1 day

Be on the lookout for a price bounce soon.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for AKTX just turned positive on July 10, 2025. Looking at past instances where AKTX's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AKTX advanced for three days, in of 206 cases, the price rose further within the following month. The odds of a continued upward trend are .

AKTX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on July 07, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on AKTX as a result. In of 108 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

AKTX moved below its 50-day moving average on June 05, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for AKTX crossed bearishly below the 50-day moving average on June 13, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 9 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AKTX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. AKTX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.694) is normal, around the industry mean (17.368). P/E Ratio (0.000) is within average values for comparable stocks, (59.372). AKTX's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.445). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (273.506).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AKTX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
AKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

AKTX is expected to report earnings to rise 426.32% to -100 cents per share on September 27

Akari Therapeutics plc AKTX Stock Earnings Reports
Q2'23
Est.
$-1.00
Q4'24
Beat
by $0.81
Q1'23
Est.
$-0.06
Q4'22
Missed
by $0.08
Q3'22
Beat
by $0.02
The last earnings report on April 15 showed earnings per share of -18 cents, beating the estimate of -100 cents. With 6.17K shares outstanding, the current market capitalization sits at 36.25M.
A.I. Advisor
published General Information

General Information

a developer of biopharmaceuticals

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
22 Boston Wharf Road
Phone
+1 929 274-7510
Employees
12
Web
https://www.akaritx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CURI4.660.07
+1.53%
CuriosityStream
AREN6.220.02
+0.32%
Arena Group Holdings (The)
HR16.190.05
+0.31%
Healthcare Realty Trust
DEO105.490.30
+0.29%
Diageo plc
GENI10.49-0.39
-3.58%
Genius Sports Limited

AKTX and Stocks

Correlation & Price change

A.I.dvisor tells us that AKTX and KPRX have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AKTX and KPRX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AKTX
1D Price
Change %
AKTX100%
+2.14%
KPRX - AKTX
30%
Poorly correlated
+1.35%
DSGN - AKTX
24%
Poorly correlated
-3.12%
MOLN - AKTX
23%
Poorly correlated
-0.84%
GLTO - AKTX
23%
Poorly correlated
+2.06%
APVO - AKTX
22%
Poorly correlated
-0.99%
More